FDA clears use of Pfizer vaccine for children 5-11

Published



Food and Drug Administration regulators cleared a Pfizer-BioNTech COVID-19 vaccine for children ages 5-11 on Friday.

The shot could be available for young children next week after the Advisory Committee on Immunization Practices for the Centers for Disease Control and Prevention reconvenes to provide feedback, after which CDC Director Rochelle Walensky will presumably give the final green light, according to the Washington Post.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.